By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > Bata India shares slip following Citi’s Sell rating
Stocks

Bata India shares slip following Citi’s Sell rating

News Room
Last updated: 2023/09/13 at 12:13 PM
By News Room
Share
2 Min Read
SHARE

© Reuters.

Shares of Bata India, a leading footwear manufacturer, declined over 3% in the opening deals on Wednesday, after Citi initiated a Sell rating on the stock with a target price of Rs 1,310. This move follows Bata’s subdued performance in Q1FY2024 and concerns about the company losing market share.

In the April-to-June quarter, Bata’s gross margins decreased by 185 basis points year-on-year (YoY) to 54.8%. The EBITDA margin also saw a decline of 92 basis points YoY to 25.5%. Demand for mass products, which are priced under Rs 1,000 ($1 = INR82.973), remained weak during this period, despite growth in the company’s premium portfolio.

Bata India’s sneaker portfolio grew by 1.15 times on a YoY basis, while Floatz, another brand towards the premium side, saw a growth of 2.06 times on a YoY basis. However, despite these developments and reach expansion initiatives, Bata’s revenue compound annual growth rate (CAGR) over FY19-23 was only 4% – the lowest among the top-four listed footwear players in India.

Citi highlighted that Bata India has lost market share and has had a zero percent volume CAGR over the past decade. In comparison, Metro Brands’ revenue has grown at a CAGR of 15% over FY19-23, while Relaxo Footwears’ revenue has grown at a CAGR of 7%in the same period.

By Wednesday afternoon, Bata India shares were down 1.11% at Rs 1681.95 on the National Stock Exchange (NSE). At the time of filing this report, the stock was trading 2.26% lower at Rs 1,662.60 on the Bombay Stock Exchange (BSE).

The brokerage further added that the reverse discounted cash flow (DCF) at the current market price (CMP) of Rs 1701.05 on the BSE implies a 17.2% revenue CAGR over FY26–36E. This is against a 10.8% revenue CAGR pre-COVID in the past decade.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

News Room September 13, 2023 September 13, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why Build-A-Bear Is Quietly Crushing The Market

Watch full video on YouTube

Economic accidents are cockroaches, not termites. 🪳

Watch full video on YouTube

Fraudsters use AI to fake artwork authenticity and ownership

Stay informed with free updatesSimply sign up to the Artificial intelligence myFT…

John Hancock Multimanager Lifestyle Moderate Portfolio Q3 2025 Commentary

A company of Manulife Investment Management, John Hancock Investment Management serves investors…

Role reversal: how foot-dragging France blindsided newly assertive Berlin

German Chancellor Friedrich Merz was making one last push to persuade EU…

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?